{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:56:09Z","timestamp":1792677369457,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.neurobiolaging.2012.10.016","type":"journal-article","created":{"date-parts":[[2012,11,17]],"date-time":"2012-11-17T07:45:57Z","timestamp":1353138357000},"page":"1116-1125","source":"Crossref","is-referenced-by-count":14,"title":["Orally bioavailable small molecule drug protects memory in Alzheimer's disease models"],"prefix":"10.1016","volume":"34","author":[{"given":"Eugene","family":"O'Hare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.C.","family":"Scopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Mee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Whyment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Spanswick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hozefa","family":"Amijee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Nerou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgeen","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Mark","family":"Treherne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Jeggo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5114\/aoms.2011.20612","article-title":"Tramiprosate in mild-to-moderate Alzheimer's disease \u2013 a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)","volume":"7","author":"Aisen","year":"2011","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JAD-2009-1044","article-title":"The quest for small molecules as amyloid inhibiting therapies for Alzheimer's disease","volume":"17","author":"Amijee","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib3","first-page":"CD003154","article-title":"Memantine for dementia","volume":"20","author":"Areosa","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-3-1","article-title":"Ginkgolides protect against amyloid-\u03b21\u201342-mediated synapse damage in\u00a0vitro","volume":"3","author":"Bate","year":"2008","journal-title":"J.\u00a0Mol. Neurodegen"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-2004-6103","article-title":"Colostrinin (a naturally occurring, proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease","volume":"6","author":"Bilikiewicz","year":"2004","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-\u03b2 protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib7","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/gps.938","article-title":"The NMDA receptor antagonist Memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence","volume":"18","author":"Danysz","year":"2003","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib8","first-page":"37","article-title":"Do cholinesterase inhibitors slow progression of Alzheimer's disease?","volume":"127","author":"Farlow","year":"2002","journal-title":"Int. J. Clin. Pract. Suppl."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-2010-1382","article-title":"Colostrinin alleviates amyloid-beta induced toxicity in rat primary hippocampal cultures","volume":"20","author":"Froud","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neurobiolaging.2006.02.015","article-title":"Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis","volume":"28","author":"Gervais","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib11","doi-asserted-by":"crossref","first-page":"29639","DOI":"10.1074\/jbc.R800016200","article-title":"Structural classification of toxic amyloid oligomers","volume":"283","author":"Glabe","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.febslet.2008.11.053","article-title":"Ovine colostrums nanopeptide affects amyloid beta aggregation","volume":"583","author":"Janusz","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1602\/neurorx.1.1.101","article-title":"Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like Memantine in the treatment of acute and chronic neurological insults","volume":"1","author":"Lipton","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib17","doi-asserted-by":"crossref","first-page":"18495","DOI":"10.1074\/jbc.M906994199","article-title":"Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta-induced toxicity","volume":"275","author":"McLaurin","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm1423","article-title":"Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model","volume":"12","author":"McLaurin","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.bjp.0704911","article-title":"A\u00a0novel \u03b2-sheet breaker, RS-0406, reverses amyloid \u03b2-induced cytotoxicity and impairment of long-term potentiation in\u00a0vitro","volume":"137","author":"Nakagami","year":"2002","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib20","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1742-4658.2008.06321.x","article-title":"Modulation of amyloid-beta aggregation and toxicity by inosose stereoisomers","volume":"275","author":"Nitz","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbr.2010.01.044","article-title":"RS-0406 arrests amyloid-beta oligomer-induced behavioural deterioration in\u00a0vivo","volume":"210","author":"O'Hare","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12017-009-8091-0","article-title":"Alzheimer's disease amyloid beta-protein and synaptic function","volume":"12","author":"Ondrejcak","year":"2010","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated NMDA receptor antagonist \u2013 a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-59745-529-9_2","article-title":"Memantine as an example of a fast, open channel N-methyl-D-aspartate receptor blocker","volume":"403","author":"Parsons","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib25","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib26","doi-asserted-by":"crossref","first-page":"9564","DOI":"10.1074\/jbc.270.16.9564","article-title":"Aggregation of secreted amyloid beta protein into sodium dodecyl sulphare-stable oligomers in cell culture","volume":"270","author":"Podlisny","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib27","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1021\/bi972029u","article-title":"Oligomerization of endogenous and synthetic amyloid beta protein at nanomolar levels in cell culture and stabilization of monomer by Congo red","volume":"37","author":"Podlisny","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbr.2008.06.001","article-title":"Oligomers of the amyloid-beta protein disrupt working memory: confirmation with two behavioural procedures","volume":"193","author":"Poling","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0091-3057(99)00101-X","article-title":"Colostrinin, a polypeptide isolated from early milk, facilitates learning and memory in rats","volume":"64","author":"Popik","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib30","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1371\/journal.pmed.0040338","article-title":"Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials","volume":"4","author":"Raschetti","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib31","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.neurobiolaging.2009.11.007","article-title":"Cognitive effects of cell-derived and synthetically derived A\u03b2 oligomers","volume":"32","author":"Reed","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib32","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nchembio0308-159","article-title":"Aggregator compounds confound amyloid fibrillization assay","volume":"4","author":"Rishton","year":"2008","journal-title":"Nature Chem. Biol."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneurol.2011.69","article-title":"Lack of evidence for the efficacy of Memantine in mild Alzheimer's disease","volume":"68","author":"Schneider","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1476-5381.2012.01973.x","article-title":"A\u03b2 oligomer toxicity inhibitor protects memory in models of synaptic toxicity","volume":"167","author":"Scopes","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/ciia.2006.1.2.131","article-title":"Treatment of Alzheimer's disease across the spectrum of severity","volume":"1","author":"Shah","year":"2006","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib37","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-\u03b2 protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-60761-744-0_3","article-title":"Isolation of low-n amyloid \u03b2-protein oligomers from cultured cells, CSF and brain","volume":"670","author":"Shankar","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1471-4159.1995.65010218.x","article-title":"The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides","volume":"65","author":"Shearman","year":"1995","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib40","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.1016\/j.bmc.2008.06.045","article-title":"Synthesis of scyllo-inositol derivatives and their effects on amyloid beta peptide aggregation","volume":"16","author":"Sun","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib41","first-page":"605","article-title":"Clearance of Alzheimer's Abeta peptide: the many roads to perdition","volume":"43","author":"Tanzi","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer's disease already receiving donepezil: a randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib43","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ana.21051","article-title":"Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers","volume":"60","author":"Townsend","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2004.11.006","article-title":"Patterns of memory impairment and perseverative behaviour discriminate early Alzheimer's disease from subcortical vascular dementia","volume":"229","author":"Traykov","year":"2005","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.phrs.2003.12.028","article-title":"The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?","volume":"50","author":"Verdile","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in\u00a0vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer's disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/0929866043407174","article-title":"Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration","volume":"11","author":"Walsh","year":"2004","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib49","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1523\/JNEUROSCI.4391-04.2005","article-title":"Certain inhibitors of synthetic amyloid \u03b2-peptide (A\u03b2) fibrillogenesis block oligomerization of natural A\u03b2 and thereby rescue long-term potentiation","volume":"25","author":"Walsh","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.016_bib50","doi-asserted-by":"crossref","first-page":"10832","DOI":"10.1021\/bi001048s","article-title":"The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain","volume":"39","author":"Walsh","year":"2000","journal-title":"Biochemistry"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012005271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012005271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T04:58:29Z","timestamp":1540097909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458012005271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0197458012005271"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.10.016","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}